SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-019041
Filing Date
2021-04-15
Accepted
2021-04-15 17:15:32
Documents
5
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A etnb-def14a_20210602.htm DEF 14A 700560
2 GRAPHIC ge2vas1xlcp3000003.jpg GRAPHIC 63864
3 GRAPHIC ge2vas1xlcp3000001.jpg GRAPHIC 9604
4 GRAPHIC ge2vas1xlcp3000002.jpg GRAPHIC 9604
5 GRAPHIC ge2vas1xlcp3000004.jpg GRAPHIC 84877
  Complete submission text file 0001564590-21-019041.txt   933449
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39122 | Film No.: 21829333
SIC: 2834 Pharmaceutical Preparations